knowledge -WSS

knowledge

author：explore 2025-10-02 02:34:58 - browse：5884

Jamy Ard (left) and Robert Lustig (right) on the 2023 STAT Breakthrough Summit stage -- coverage from STAT — Obesity experts Jamy Ard (left) and Robert Lustig speak at a panel during the 2023 STAT Breakthrough Summit. Sarah Gonzalez for STAT

Amid rising demand for drugs like Wegovy, Ozempic, and Mounjaro that can lead to significant weight loss, some obesity experts are concerned about the drugs’ costs — both to patients’ finances and to their health.

Speaking at a panel on new obesity treatments at the STAT Breakthrough Summit in San Francisco on Thursday, one expert cited a large clinical trial for Wegovy that showed that about 40% of the weight participants lost was lean mass. Side effects like nausea, vomiting, and a possible link to rare cases of pancreatitis also still plague this newest class of drugs, which imitate the effects of a hormone called glucagon-like peptide 1 (GLP) that helps people feel full.

“That’s what starvation does. You lose equal amounts of muscle and fat,” said Robert Lustig, emeritus professor of pediatrics at the University of California, San Francisco. “If you’re a person 60 years old or over and you’re losing muscle, your risk of dying just went up exponentially. So we may be … robbing Peter to pay Paul.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： Tome Biosciences co

WSS

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Profiling embryos to choose those with higher IQs is almost a reality

STAT Virtual Event: JPM Recap, Live!

Arena BioWorks launches in Cambridge to speed drug discovery

Having children helps parents live longer, especially after age 80

Wikipedia

knowledge

knowledge

Jerome Adams on the need for new antivirals for Covid

Allen Institute goes after foundational questions, CEO Costa says

Wildfire smoke exposes gaps in outdoor worker protections

Male doctors called my cancer incurable. A female doctor showed it wasn't

Apple is now the first public company to be valued at $3 trillion

Profiling embryos to choose those with higher IQs is almost a reality

Sports medicine is finally prioritizing gender equality

Gene therapy denied for Afghan refugee whose father aided U.S.

Activists slam private health insurers over coverage restrictions

Physician assistants need a new name. Here's what it should be

focus

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Bernie Sanders gets little from pharma CEOs on drug prices

AMAs digital advisors table RPM coding reform proposal, again

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Congress must protect the remaining independent doctors

Boston Scientific acquires urology company Axonics for $3.7 billion

knowledge

explore

entertainment

focus